| Dr Gregory Phillip Root, DO | |
|
1205 Health Center Pkwy Ste 240, Yukon, OK 73099-6396 | |
| (405) 717-5496 | |
| (405) 717-5499 |
| Full Name | Dr Gregory Phillip Root |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 9 Years |
| Location | 1205 Health Center Pkwy Ste 240, Yukon, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467748889 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 5273 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Integris Canadian Valley Hospital | Yukon, OK | Hospital |
| Integris Baptist Medical Center, Inc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Integris Ambulatory Care Corporation | 2365408465 | 382 |
News Archive
There has been a significant increase in cancers which are linked to alcohol over the past ten years, according to figures requested by the Liberal Democrats.
Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.
The U.S. Food and Drug Administration's Office of Orphan Products Development has awarded Seattle Children's Research Institute a $1.6 million grant to lead a 4-year, multi-site clinical trial aimed at improving long-term health in infants born with a heart defect.
Between 1999 and 2010, periods of extreme heat in the U.S. were associated with an increased risk of hospitalization for older adults for fluid and electrolyte disorders, kidney failure, urinary tract infections, septicemia and heat stroke, according to a study in the December 24/31 issue of JAMA.
› Verified 8 days ago
| Entity Name | Integris Ambulatory Care Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750333936 PECOS PAC ID: 2365408465 Enrollment ID: O20041209000354 |
News Archive
There has been a significant increase in cancers which are linked to alcohol over the past ten years, according to figures requested by the Liberal Democrats.
Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.
The U.S. Food and Drug Administration's Office of Orphan Products Development has awarded Seattle Children's Research Institute a $1.6 million grant to lead a 4-year, multi-site clinical trial aimed at improving long-term health in infants born with a heart defect.
Between 1999 and 2010, periods of extreme heat in the U.S. were associated with an increased risk of hospitalization for older adults for fluid and electrolyte disorders, kidney failure, urinary tract infections, septicemia and heat stroke, according to a study in the December 24/31 issue of JAMA.
› Verified 8 days ago
| Entity Name | Oklahoma City Gynecology And Obstetrics, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114987633 PECOS PAC ID: 4284684606 Enrollment ID: O20050330001202 |
News Archive
There has been a significant increase in cancers which are linked to alcohol over the past ten years, according to figures requested by the Liberal Democrats.
Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.
The U.S. Food and Drug Administration's Office of Orphan Products Development has awarded Seattle Children's Research Institute a $1.6 million grant to lead a 4-year, multi-site clinical trial aimed at improving long-term health in infants born with a heart defect.
Between 1999 and 2010, periods of extreme heat in the U.S. were associated with an increased risk of hospitalization for older adults for fluid and electrolyte disorders, kidney failure, urinary tract infections, septicemia and heat stroke, according to a study in the December 24/31 issue of JAMA.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gregory Phillip Root, DO 5300 N Independence Ave Ste 280, Oklahoma City, OK 73112-5555 Ph: (405) 717-5496 | Dr Gregory Phillip Root, DO 1205 Health Center Pkwy Ste 240, Yukon, OK 73099-6396 Ph: (405) 717-5496 |
News Archive
There has been a significant increase in cancers which are linked to alcohol over the past ten years, according to figures requested by the Liberal Democrats.
Exoskeleton leader ReWalk Robotics announced today that the U.S. Food and Drug Administration has cleared the company's ReWalk Personal System for use at home and in the community. ReWalk is a wearable robotic exoskeleton that provides powered hip and knee motion to enable individuals with Spinal Cord Injury (SCI) to stand upright and walk.
Schering-Plough Corporation reported that interim results from an ongoing Phase IIa study of narlaprevir (SCH 900518), its investigational, once-daily protease inhibitor, demonstrated potent antiviral activity in treatment-naive patients with chronic hepatitis C virus (HCV) genotype 1.
The U.S. Food and Drug Administration's Office of Orphan Products Development has awarded Seattle Children's Research Institute a $1.6 million grant to lead a 4-year, multi-site clinical trial aimed at improving long-term health in infants born with a heart defect.
Between 1999 and 2010, periods of extreme heat in the U.S. were associated with an increased risk of hospitalization for older adults for fluid and electrolyte disorders, kidney failure, urinary tract infections, septicemia and heat stroke, according to a study in the December 24/31 issue of JAMA.
› Verified 8 days ago
Dawn Rachelle Wilson, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 436 S Mustang Rd, Yukon, OK 73099 Phone: 405-265-2733 Fax: 405-265-2926 | |
Joseph Caleb Mitro, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1205 Health Center Pkwy Ste 240, Yukon, OK 73099 Phone: 405-717-5496 Fax: 405-717-5499 | |
Kathryn Lee Jones, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1205 Health Center Pkwy, Suite 240b, Yukon, OK 73099 Phone: 405-717-5496 Fax: 405-717-5320 | |
Dr. Elise Marie Schrop, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1205 Health Center Pkwy, Suite 240b, Yukon, OK 73099 Phone: 405-717-5496 Fax: 405-717-5320 |